|
ELL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.616000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.744990E-01 |
| Normal-vs-Stage2 |
8.675000E-01 |
| Normal-vs-Stage3 |
8.645600E-01 |
| Normal-vs-Stage4 |
9.115400E-01 |
| Stage1-vs-Stage2 |
2.987800E-01 |
| Stage1-vs-Stage3 |
1.665410E-01 |
| Stage1-vs-Stage4 |
3.579600E-01 |
| Stage2-vs-Stage3 |
9.585800E-01 |
| Stage2-vs-Stage4 |
8.134400E-01 |
| Stage3-vs-Stage4 |
8.020400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.873200E-01 |
| Normal-vs-AfricanAmerican |
6.835200E-03 |
| Normal-vs-Asian |
6.208200E-01 |
| Caucasian-vs-AfricanAmerican |
4.936000E-03 |
| Caucasian-vs-Asian |
5.435800E-01 |
| AfricanAmerican-vs-Asian |
4.811800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.793200E-01 |
| Normal-vs-Female |
2.882400E-02 |
| Male-vs-Female |
3.903000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.647600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.698400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.994800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.469800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.927600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.750800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.230200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.574800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.838400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.149400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.632270E-04 |
| Normal-vs-Grade 2 |
1.869830E-01 |
| Normal-vs-Grade 3 |
7.884800E-01 |
| Normal-vs-Grade 4 |
5.702200E-01 |
| Grade 1-vs-Grade 2 |
3.044100E-02 |
| Grade 1-vs-Grade 3 |
1.557410E-03 |
| Grade 1-vs-Grade 4 |
8.786500E-04 |
| Grade 2-vs-Grade 3 |
8.864000E-02 |
| Grade 2-vs-Grade 4 |
8.758400E-02 |
| Grade 3-vs-Grade 4 |
7.198000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.738000E-01 |
| Normal-vs-ccB subtype |
2.797000E-01 |
| ccA subtype-vs-ccB subtype |
8.290000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.355000E-01 |
| Normal-vs-N1 |
7.054600E-01 |
| N0-vs-N1 |
5.651200E-01 |
|
|
